Evidence map›Paper›PMID 29943199›Full record

ArticleJournal of molecular modeling2018

A residue of motif III positions the helicase domains of motor subunit HsdR in restriction-modification enzyme EcoR124I.

Dhiraj Sinha, Vitali Bialevich, Katsiaryna Shamayeva, Alena Guzanova, Alexandra Sisakova, Eva Csefalvay, David Reha, Lumir Krejci, Jannette Carey, Marie Weiserova and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Dhiraj SinhaCenter for Nanobiology and Structural Biology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Zamek 136, CZ-373 33, Nove Hrady, Czech Republic.
Vitali BialevichCenter for Nanobiology and Structural Biology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Zamek 136, CZ-373 33, Nove Hrady, Czech Republic.
Katsiaryna ShamayevaCenter for Nanobiology and Structural Biology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Zamek 136, CZ-373 33, Nove Hrady, Czech Republic.
Alena GuzanovaInstitute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20, Praha 4, Czech Republic.
Alexandra SisakovaDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Kamenice 5/A7, 625 00, Brno, Czech Republic.
Eva CsefalvayCenter for Nanobiology and Structural Biology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Zamek 136, CZ-373 33, Nove Hrady, Czech Republic.
David RehaCenter for Nanobiology and Structural Biology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Zamek 136, CZ-373 33, Nove Hrady, Czech Republic.
Lumir KrejciDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Kamenice 5/A7, 625 00, Brno, Czech Republic.
Jannette CareyCenter for Nanobiology and Structural Biology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Zamek 136, CZ-373 33, Nove Hrady, Czech Republic.
Marie WeiserovaInstitute of Microbiology, Academy of Sciences of the Czech Republic, Vídeňská 1083, 142 20, Praha 4, Czech Republic.
Rüdiger EttrichCenter for Nanobiology and Structural Biology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Zamek 136, CZ-373 33, Nove Hrady, Czech Republic. ettrich@nh.cas.cz.ORCID http://orcid.org/0000-0001-8624-7706
Czech Academy of Sciences · CZMasaryk University · CZPrinceton University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type I restriction-modification enzymes differ significantly from the type II enzymes commonly used as molecular biology reagents. On hemi-methylated DNAs type I enzymes like the EcoR124I restriction-modification complex act as conventional adenine methylases at their specific target sequences, but unmethylated targets induce them to translocate thousands of base pairs through the stationary enzyme before cleaving distant sites nonspecifically. EcoR124I is a superfamily 2 DEAD-box helicase like eukaryotic double-strand DNA translocase Rad54, with two RecA-like helicase domains and seven characteristic sequence motifs that are implicated in translocation. In Rad54 a so-called extended region adjacent to motif III is involved in ATPase activity. Although the EcoR124I extended region bears sequence and structural similarities with Rad54, it does not influence ATPase or restriction activity as shown in this work, but mutagenesis of the conserved glycine residue of its motif III does alter ATPase and DNA cleavage activity. Through the lens of molecular dynamics, a full model of HsdR of EcoR124I based on available crystal structures allowed interpretation of functional effects of mutants in motif III and its extended region. The results indicate that the conserved glycine residue of motif III has a role in positioning the two helicase domains.

Indexed as

Protein Interaction Domains and MotifsAdenosine TriphosphateAmino Acid SequenceDeoxyribonucleases, Type I Site-SpecificDNA HelicasesEnzyme ActivationHydrolysisMolecular Dynamics SimulationMultienzyme ComplexesMutationPrincipal Component AnalysisProtein ConformationProtein SubunitsAdenosine TriphosphateDeoxyribonucleases, Type I Site-SpecificDNA HelicasesMultienzyme ComplexesProtein SubunitsDNA restriction enzymesDomain interactionsMolecular mechanicsMolecular modelingMultisubunit enzyme complexPrincipal components analysis

Identifiers

PMID29943199
OpenAlexW2811318374

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.